monoclonal antibody Treatment of cutaneous T-cell lymphoma with chimeric anti-CD4

[1]  D. Rizzieri,et al.  Radioimmunotherapy for Non-Hodgkin's Lymphoma. , 2005, Clinical medicine & research.

[2]  Knox,et al.  Radioimmunotherapy of the Non-Hodgkin's Lymphomas. , 1995, Seminars in radiation oncology.

[3]  L. Golitz,et al.  Systemic Therapy of Cutaneous T-Cell Lymphomas (Mycosis Fungoides and the Sezary Syndrome) , 1994, Annals of Internal Medicine.

[4]  T. Kuzel,et al.  Mycosis fungoides and the Sézary syndrome: a review of pathogenesis, diagnosis, and therapy. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  Young Rc.  Mycosis fungoides: the therapeutic search continues. , 1989 .

[6]  A. M. Zimmer,et al.  Radioimmunodetection and radioimmunotherapy of cutaneous T cell lymphomas using an 131I-labeled monoclonal antibody: an Illinois Cancer Council Study. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  A. Levine,et al.  Monoclonal antibody T101 in T cell malignancies: a clinical, pharmacokinetic, and immunologic correlation. , 1986, Blood.

[8]  R. Warnke,et al.  Leu-8 and Leu-9 antigen phenotypes: immunologic criteria for the distinction of mycosis fungoides from cutaneous inflammation. , 1986, Journal of the American Academy of Dermatology.

[9]  R. Warnke,et al.  Advantages of detecting monoclonal antibody binding to tissue sections with biotin and avidin reagents in Coplin jars. , 1986, American journal of clinical pathology.

[10]  R. Dillman,et al.  Therapy of chronic lymphocytic leukemia and cutaneous T-cell lymphoma with T101 monoclonal antibody. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  Ronald Levy,et al.  Monoclonal antibody therapeutic trials in seven patients with T-cell lymphoma , 1983 .

[12]  Richard A. Miller,et al.  RESPONSE OF CUTANEOUS T CELL LYMPHOMA TO THERAPY WITH HYBRIDOMA MONOCLONAL ANTIBODY , 1981, The Lancet.